The All-in-One Drug Generator is an AI-driven technology capable of precisely generating candidate small-molecule drugs based on specific therapeutic requirements. Developed by Graphen Drugomics Inc. and integrated into the Atom Platform, this technology is trained on both small- and large-molecule structures as well as experimental language, enabling it to perform accurate conditional generation and internal optimization in iterative cycles.
Leveraging multimodal features, we integrate advanced drug design to support complex multi-target, multi-drug scenarios, improving the success rate of drug development.
Utilizing precision small molecule generation technology, we design novel and effective drugs for a variety of diseases, shortening the early drug development process from the traditional 2-4 years to just 6-12 months.
Our vision is to push the boundaries of artificial intelligence to solve complex challenges and shape a better future. We’re passionate about creating intelligent solutions that drive meaningful change across industries and communities. Through innovation, collaboration, and a commitment to excellence, we aim to set new standards in AI development.
I804229
I815572
I857617
Artificial Intelligence Acute Kidney Injury Prediction: Real-time Inference and Interactive Critical Care System
Revolutionary CAR-sEV: Non-Genetically Modified Targeted Stem Cell-Derived Exosome Drugs for Precision Medicine Applications
Next-Gen Wireless Magnetoelectric Gene Delivery Hydrogel for Neuroregenerative miRNA Sponge Generation in Traumatic Brain Injury
Universal Hypoimmunogenic Allogeneic iPSC Source Bank: Driving Industrialization and Clinical Breakthroughs in Regenerative Medicine
Technology maturity:Mass production
Exhibiting purpose:Product promotion
Trading preferences:Negotiate by self
*Organization
*Name
*Phone
*Main Purpose
*Discuss Further
*Job Category
*Overall Rating
*Favorite Area
*Key Tech Focus
*Willing to Receive Updates?
Other Suggestions
Coming soon!